lp
escherichia
coli
purchas
sigmaaldrich
st
loui
mo
usa
ma
receptor
antagonist
obtain
abbiotech
san
diego
ca
usa
inhibitor
product
emd
millipor
darmstadt
germani
specif
inhibitor
mapk
specif
inhibitor
specif
inhibitor
jnk
purchas
santa
cruz
biotechnolog
delawar
ca
usa
rabbit
mous
antibodi
procur
santa
cruz
biotechnolog
rabbit
mapk
mapk
antijnk
antiphosphojnk
horseradish
peroxidas
hrp
conjug
goat
antirabbit
igg
hors
antimous
igg
antibodi
purchas
cell
signal
technolog
danver
usa
kit
purchas
invitrogen
eugen
usa
angii
ang
enzymelink
immunosorb
assay
elisa
kit
kamiya
biomed
seattl
wa
usa
male
spraguedawley
rat
weigh
g
obtain
depart
laboratori
anim
scienc
shanghai
jiaotong
univers
shanghai
china
anim
hous
free
access
food
water
temperaturecontrol
room
experiment
procedur
approv
ethic
committe
anim
research
colleg
medicin
shanghai
jiaotong
univers
shanghai
china
conduct
accord
intern
guidelin
care
use
laboratori
anim
accord
sequenc
rat
mrna
design
sirna
sequenc
target
code
region
correspond
oligonucleotid
templat
shrna
chemic
synthes
clone
shrna
vector
system
bioscienc
california
usa
digest
bamhi
ecori
purifi
agaros
gel
electrophoresi
scrambl
rnai
sequenc
use
neg
control
result
plasmid
select
confirm
direct
dna
sequenc
total
rna
extract
rat
pmvec
cell
revers
transcrib
cdna
use
mmlv
revers
transcriptas
takara
bio
japan
use
amplifi
code
sequenc
use
follow
primer
forward
primer
revers
primer
product
purifi
ligat
linear
lentivector
pcdnacmvcopgfp
cdna
vector
system
bioscienc
usa
ligat
mixtur
transform
compet
strain
posit
clone
select
plasmid
extract
analyz
pcr
sequenc
accord
manufactur
instruct
express
vector
shrna
vector
lentiviru
packag
plasmid
mix
cotransfect
produc
cell
use
invitrogen
ca
usa
supernat
collect
hour
later
clear
centrifug
filter
pvdf
membran
viral
titer
evalu
gradient
dilut
packag
lentivirus
design
deliveri
recombin
lentiviru
carri
cdna
recombin
lentiviru
carri
shrna
lung
rat
underw
midlin
incis
expos
trachea
isofluran
anesthesia
briefli
anesthet
rat
place
supin
posit
inclin
platform
approxim
trachea
expos
surgic
ventral
side
neck
needl
insert
tracheal
wall
lumen
blow
larynx
empti
viru
control
viral
particl
phosphatebuff
salin
directli
inject
trachea
follow
air
enhanc
spread
viru
rat
lung
inject
perform
day
later
one
week
last
lentivir
treatment
anim
subject
lp
administr
acut
lung
injuri
ali
induc
singl
intraven
inject
lp
mgkg
previous
control
rat
receiv
nacl
solut
tail
vein
treatment
group
mgkg
inject
via
rat
tail
vein
min
induct
ali
anim
breath
spontan
experiment
protocol
eight
hour
lp
administr
anim
anesthet
intraperiton
inject
pentobarbit
sodium
mgkg
euthan
exsanguin
serum
sampl
collect
store
bronchoalveolar
lavag
fluid
balf
collect
three
lavag
sampl
left
lung
aliquot
ml
normal
salin
greater
recoveri
salin
achiev
retriev
balf
pool
centrifug
g
min
supernat
store
aliquot
right
lung
fix
immedi
paraformaldehyd
investig
role
mapk
pathway
develop
ard
effect
overexpress
mapk
specif
inhibitor
mgkg
pretreat
intraperiton
time
min
lp
administr
embed
lung
tissu
cut
section
stain
hematoxylineosin
microscop
observ
degre
lung
injuri
semiquantit
score
describ
murakami
briefli
lung
injuri
score
includ
edema
inflamm
hemorrhag
grade
follow
scale
normal
light
moder
strong
sever
analysi
conduct
pathologist
blind
experiment
group
valu
three
paramet
analyz
ad
final
lung
injuri
score
averag
score
calcul
within
experiment
group
assess
lung
permeabl
rat
protein
concentr
bal
fluid
measur
briefli
balf
sampl
left
lung
centrifug
g
min
protein
concentr
supernat
quantifi
bca
protein
assay
pierc
il
usa
balf
level
angii
ang
measur
use
elisa
assay
accord
manufactur
instruct
total
protein
extract
frozen
lung
tissu
use
tper
tissu
protein
extract
reagent
pierc
il
usa
equal
amount
protein
run
sdspage
gel
transfer
onto
polyvinyliden
difluorid
membran
millipor
membran
block
skim
milk
tbst
room
temperatur
h
incub
primari
antibodi
rat
phosphoryl
jnk
phosphoryl
jnk
mapk
phosphoryl
mapk
phosphoryl
actin
overnight
wash
tbst
blot
incub
secondari
hrpconjug
antimouserabbit
igg
room
temperatur
h
wash
tbst
membran
develop
ecl
detect
kit
pierc
il
usa
imag
xray
film
total
rna
extract
lung
tissu
trizol
reagent
invitrogen
usa
quantit
realtim
pcr
perform
use
thermal
cycler
dice
real
time
system
takara
japan
briefli
solut
rna
mix
oligo
dt
primer
dilut
final
volum
rnase
free
distil
water
incub
min
kept
ice
min
solut
mix
buffer
mm
dntp
mixtur
takara
ribonucleas
inhibitor
takara
rnase
mmlv
dilut
rnase
incub
min
min
next
reaction
mixtur
contain
cdna
primer
f
primer
r
sybr
premix
ex
taq
takara
dilut
rnase
kept
min
reaction
condit
follow
cycl
sec
sec
sec
method
use
analyz
rel
mrna
level
target
gene
fold
chang
normal
betaactin
gene
rel
sham
group
follow
primer
use
forward
primer
revers
primer
ma
forward
primer
revers
primer
forward
primer
revers
primer
statist
analys
perform
prism
softwar
packag
graphpad
san
diego
ca
usa
valu
present
mean
standard
deviat
sd
data
analyz
use
oneway
anova
newmankeul
test
multipl
comparison
pvalu
less
consid
statist
signific
compar
control
anim
mrna
protein
level
lung
tissu
group
rat
lung
transfect
increas
fold
respect
contrast
mrna
protein
level
infect
rat
lung
group
decreas
signific
differ
mrna
protein
express
control
group
lvnc
group
rat
lung
transfect
recombin
lentiviru
carri
neg
control
shrna
result
show
high
effici
gene
transfer
rat
lung
via
intratrach
inject
fig
hour
lp
treatment
result
acut
lung
injuri
demonstr
edema
inflamm
hemorrhag
fig
lung
injuri
score
fig
balf
protein
level
fig
lp
group
significantli
increas
compar
control
group
overexpress
rat
lung
markedli
attenu
lpsinduc
lung
injuri
decreas
lung
injuri
score
balf
protein
level
sharp
contrast
silenc
notic
deterior
lpsinduc
lung
injuri
evidenc
increas
lung
injuri
score
balf
protein
level
furthermor
pretreat
either
potent
select
antagonist
ang
via
competit
bind
specif
ma
receptor
inhibitor
significantli
inhibit
protect
effect
lpsinduc
lung
injuri
lung
injuri
score
balf
protein
level
group
significantli
higher
group
suggest
protect
rat
lpsinduc
acut
lung
injuri
partial
via
masmedi
signal
lp
administr
level
ang
ii
fig
ang
fig
balf
significantli
increas
compar
control
group
overexpress
significantli
reduc
balf
ang
ii
concentr
enhanc
ang
level
ratio
ang
ii
ang
markedli
drop
lp
group
group
pretreat
transduc
rat
revers
decreas
ang
ii
level
increas
ang
level
balf
ratio
ang
ii
ang
notabl
increas
group
group
respect
addit
rnai
also
significantli
increas
ang
ii
level
decreas
ang
level
ratio
ang
ii
ang
increas
highest
level
group
fig
fig
fig
concentr
balf
rat
expos
lp
significantli
higher
control
group
lpsinduc
secret
balf
dramat
inhibit
overexpress
promot
knockdown
rat
balf
treatment
prior
lp
inject
result
obviou
increas
balf
rat
transduc
concentr
balf
group
group
similar
lp
group
result
demonstr
lp
mainli
promot
gener
ang
ii
enhanc
cytokin
secret
abolish
overexpress
overexpress
rat
lung
significantli
enhanc
lpsinduc
secret
balf
abolish
pretreat
interestingli
knockdown
rat
lung
also
promot
level
balf
lp
administr
result
suggest
antiinflammatori
respons
may
also
trigger
lung
lp
exposur
counter
effect
proinflammatori
cytokin
promot
antiinflammatori
respons
via
ang
ma
pathway
lp
administr
result
signific
decreas
protein
rat
lung
upregul
transduct
attenu
fig
upregul
protein
express
rat
lung
suppress
pretreat
lp
inject
express
group
similar
lp
group
ma
mrna
upregul
lung
tissu
rat
expos
lp
overexpress
caus
signific
increas
ma
mrna
lp
stimul
rat
lung
knockdown
markedli
suppress
ma
mrna
express
treatment
lp
administr
significantli
reduc
express
ma
mrna
transduc
rat
lung
signific
differ
ma
mrna
express
group
control
group
fig
western
blot
result
show
lp
administr
induc
phosphoryl
mapk
fig
fig
jnk
fig
overexpress
significantli
suppress
phosphoryl
level
mapk
jnk
lung
tissu
rat
receiv
lp
inhibitori
effect
overexpress
lpsinduc
mapk
phosphoryl
complet
abolish
pretreat
meanwhil
signific
differ
jnk
phosphoryl
compar
group
addit
knock
rat
lung
significantli
enhanc
lpsinduc
increas
jnk
phosphoryl
rat
lung
signific
differ
mapk
phosphoryl
level
group
lp
group
fig
pretreat
specif
mapk
inhibitor
infect
rat
attenu
lpsinduc
lung
injuri
evidenc
reduc
lung
injuri
score
balf
protein
level
fig
b
e
balf
protein
level
rat
group
group
significantli
reduc
pretreat
lpsinduc
lung
injuri
also
attenu
mpak
inhibitor
prior
lp
administr
rat
two
group
fig
f
g
howev
evalu
lung
injuri
score
show
statist
differ
rat
without
mpak
inhibitor
pretreat
group
group
except
rat
group
pretreat
show
signific
decreas
lung
injuri
score
fig
addit
balf
cytokin
dramat
reduc
specif
mapk
inhibitor
pretreat
rat
group
fig
result
indic
block
mapk
pathway
remark
attenu
lpsinduc
inflammatori
respons
infect
rat
pretreat
rat
overexpress
furthermor
histolog
evalu
whole
lung
injuri
demonstr
pretreat
specif
mapk
inhibitor
significantli
attenu
lpsinduc
lung
injuri
infect
rat
significantli
revers
blockad
effect
overexpress
prevent
lpsinduc
lung
injuri
special
inhibit
pathway
significantli
attenu
lpsinduc
cytokin
secret
lung
injuri
overexpress
rat
pretreat
ma
receptor
antagonist
eight
hour
lp
administr
phosphoryl
level
significantli
increas
express
clearli
decreas
lung
compar
control
rat
overexpress
rat
lung
markedli
suppress
lpsinduc
phosphoryl
enhanc
express
complet
abolish
pretreat
furthermor
phosphoryl
level
higher
group
group
lp
group
compar
lp
group
downregul
enhanc
lpsinduc
increas
phosphoryl
level
lung
tissu
differ
phosphoryl
level
lp
group
group
meanwhil
express
level
group
significantli
lower
control
group
still
higher
compar
lp
group
fig
studi
demonstr
lp
administr
evok
sever
lung
injuri
character
increas
inflammatori
cell
infiltr
edema
hemorrhag
interstitium
alveolu
well
increas
level
balf
result
also
show
lp
administr
significantli
reduc
express
rat
lung
wherea
overexpress
significantli
attenu
lpsinduc
lung
injuri
suppress
inflammatori
respons
abolish
inhibitor
knockdown
caus
mark
deterior
lung
injuri
increas
cytokin
secret
rat
receiv
lp
inject
togeth
find
suggest
local
lung
tissu
prevent
lpsinduc
lung
injuri
inflamm
may
use
therapeut
agent
target
ard
activ
reninangiotensin
system
play
central
role
pathophysiolog
ard
suppress
aceang
axi
shown
improv
symptom
differ
ard
model
loss
mice
result
aggrav
lung
injuri
wherea
recombin
attenu
symptom
ard
mice
especi
wild
type
lung
injuri
ard
mous
model
caus
limb
ischemiareperfus
lir
deterior
deplet
protect
transgen
chang
express
lung
tissu
accompani
alter
ang
iiang
prior
studi
shown
downregul
express
lung
increas
serum
ang
ii
level
associ
sever
respiratori
syncyti
viru
ard
also
amelior
administr
recombin
human
moreov
decreas
activ
balf
ventil
anim
expos
lp
correl
enhanc
balf
ang
ii
reduc
ang
similar
previou
studi
result
show
overexpress
rat
lung
reduc
balf
ang
ii
level
increas
ang
level
anim
treat
lp
ratio
ang
ii
ang
balf
significantli
decreas
overexpress
markedli
increas
knockdown
despit
evid
suggest
decreas
ang
level
lung
tissu
develop
ard
conflict
result
publish
literatur
ang
level
balf
increas
mechan
ventilationinduc
rat
lung
injuri
decreas
hour
lp
mous
ard
model
ang
lung
tissu
shown
decreas
hour
lp
earli
stage
lirinduc
ard
lung
tissu
ang
level
significantli
increas
hour
persist
hour
present
studi
found
lp
administr
caus
signific
increas
ang
ii
also
unexpect
increas
ang
balf
reninangiotensin
system
ang
mainli
gener
hydrolyz
ang
ii
also
gener
ace
catalyz
ang
possibl
increas
level
ang
lung
tissu
may
play
compensatori
role
initi
develop
ard
discoveri
ang
major
product
stimul
downstream
ma
receptor
oppos
effect
ang
suggest
ang
may
contribut
protect
effect
support
hypothesi
ang
overexpress
lung
tissu
prevent
bleomycininduc
lung
injuri
blockad
ma
receptor
abolish
benefici
effect
ang
monocrotalineinduc
pulmonari
ang
ma
agonist
prevent
ventil
acid
aspirationinduc
lung
injuri
revers
ma
receptor
present
studi
demonstr
ma
receptor
antagonist
effect
abolish
protect
effect
overexpress
lung
rat
expos
lp
addit
ma
receptor
antagonist
also
revers
decreas
ang
ii
increas
ang
balf
transduc
rat
elev
ang
iiang
ratio
result
indic
protect
effect
lpsinduc
lung
injuri
primarili
depend
ang
ma
pathway
recent
studi
found
infus
ang
enhanc
ma
mrna
express
bleomycininduc
lung
injuri
furthermor
overexpress
rostral
ventrolater
medulla
spontan
hypertens
rat
increas
express
studi
found
overexpress
result
signific
increas
ma
mrna
express
lpsstimul
rat
lung
knockdown
remark
suppress
ma
mrna
express
moreov
blockad
ma
receptor
reduc
express
lung
tissu
also
significantli
suppress
ma
mrna
express
data
suggest
protect
effect
lung
injuri
depend
ma
signal
cascad
also
upregul
ma
receptor
express
underli
molecular
mechan
protect
ard
remain
elus
previou
studi
indic
activ
mapk
signal
promot
progress
function
linkag
mapk
pathway
ma
signal
axi
lpsinduc
lung
injuri
elucid
current
studi
show
lp
administr
stimul
phosphoryl
mapk
jnk
significantli
reduc
overexpress
lung
tissu
moreov
shrna
enhanc
phosphoryl
jnk
rat
lung
either
ma
receptor
antagonist
inhibitor
complet
abolish
inhibitori
effect
lpsinduc
mapk
phosphoryl
combin
chang
ang
iiang
ma
mrna
result
suggest
protect
lpsinduc
ard
reli
ang
ma
pathway
inhibit
signal
cascad
mapk
similar
find
xue
et
al
found
overexpress
rat
lung
attenu
smokinginduc
lung
inflamm
via
inhibit
mapk
song
b
et
al
report
recombin
human
prevent
ang
iimedi
myocardi
injuri
block
activ
addit
shown
regul
balanc
angiiang
prevent
alveolar
epitheli
cell
apoptosi
jnk
phosphoryl
pretreat
abolish
antiapoptot
effect
ang
inhibit
jnk
overexpress
pmvec
protect
lpsinduc
apoptosi
suppress
mapkjnk
phosphoryl
attenu
pretreat
data
indic
suppress
mapk
activ
ma
signal
pathway
cell
type
depend
investig
whether
mapk
pathway
play
role
protect
effect
lpsinduc
lung
injuri
specif
mapk
inhibitor
pretreat
intraperiton
rat
receiv
lp
inject
pretreat
jnk
inhibitor
significantli
attenu
lpsinduc
inflammatori
respons
injuri
rat
lung
knockdown
moreov
ma
receptor
antagonist
inhibitor
abolish
protect
effect
overexpress
lpsinduc
protein
cytokin
secret
balf
obvious
revers
specif
mapk
inhibitor
wherea
inhibitor
significantli
attenu
lung
injuri
overexpress
rat
pretreat
result
suggest
may
signal
pathway
involv
mechan
protect
effect
lpsinduc
lung
injuri
famili
includ
rela
relb
crel
exist
homo
heterodim
cytoplasm
maintain
inact
state
bind
protein
upon
stimul
lp
proinflammatori
cytokin
protein
phosphoryl
activ
kinas
ikk
degrad
lead
activ
transloc
nucleu
upregul
transcript
inflammatori
activ
pivot
develop
endotoxininduc
ard
imai
et
al
identifi
signal
pathway
key
role
control
sever
acut
lung
present
vivo
studi
overexpress
rat
lung
significantli
suppress
lpsinduc
phosphoryl
enhanc
express
complet
revers
ma
receptor
antagonist
inhibitor
pretreat
contrast
overexpress
silenc
markedli
enhanc
lpsinduc
activ
degrad
result
indic
signal
pathway
also
import
may
cooper
mapk
pathway
facilit
protect
effect
lpsinduc
ard
result
vitro
studi
also
suggest
prevent
pmvec
lpsinduc
apoptosi
inflamm
inhibit
jnk
find
consist
previou
observ
pharmacolog
inhibit
erk
attenu
lpsinduc
lung
injuri
via
suppress
activ
nfkb
summari
previou
studi
data
present
suggest
protect
lung
injuri
like
via
gener
ang
turn
stimul
masmedi
signal
inhibit
activ
process
ard
fig
clinic
intraven
administr
recombin
human
healthi
human
result
increas
decreas
unchang
ang
serum
concentr
without
cardiovascular
clinic
trial
perform
petti
wj
et
al
ang
administr
led
decreas
plasma
placent
growth
factor
level
cancer
patient
clinic
suggest
ang
ma
pathway
promis
therapeut
target
ard
cite
articl
li
et
al
angiotensinconvert
enzym
prevent
lipopolysaccharideinduc
rat
acut
lung
injuri
via
suppress
signal
pathway
sci
rep
doi
